Right Answer: a) This option is the most immediate and critical next step in the management of MH. The standard initial dose of dantrolene is 2.5 mg/kg, and a single 1 mg/kg bolus is often insufficient to reverse the MH crisis. The persistence of tachycardia and high EtCO2 despite the initial dose indicates a need for further dantrolene administration. The maximum cumulative dose can be up to 10 mg/kg.
Explaination:
The clinical presentation of unexplained tachycardia, an increase in EtCO2, and hyperthermia in a patient undergoing scoliosis correction with isoflurane and nitrous oxide is highly suggestive of malignant hyperthermia (MH).
Malignant hyperthermia (MH) is a rare but serious genetic disorder that causes a hypermetabolic state in skeletal muscles. It's often triggered by certain anaesthetics.
The immediate treatment involves:
Administering Dantrolene: The initial dose is 2.5 mg/kg as a bolus, which can be repeated with 1 mg/kg doses as needed until symptoms subside. The total cumulative dose can go up to 10 mg/kg.
Removing the Trigger: The anesthetic agents, such as isoflurane, that triggered the event must be immediately stopped.
Active Cooling: The patient's body temperature must be lowered using methods like cold intravenous fluids, cooling blankets, or ice packs.
Supportive Care: Anesthesia should be maintained using non-triggering agents like total intravenous anesthesia (TIVA).
Throughout this crisis, continuous monitoring is crucial. This includes:
Vital Signs: End-tidal CO2 (EtCO2), arterial blood pressure, and core and peripheral temperatures.
Blood Work: Arterial blood gases to check for acidosis, as well as levels of potassium, creatine kinase, and clotting factors.
Urine: Monitoring urine output and pH for signs of myoglobinuria, which can indicate severe muscle breakdown and potential kidney damage.
Systemic complications of MH can include high potassium levels (hyperkalemia), irregular heart rhythms, muscle tissue breakdown (myoglobinemia), and a serious bleeding disorder called disseminated intravascular coagulation (DIC).
